• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

考察巴尔斯成人注意缺陷多动障碍评定量表第四版(BAARS-IV)作为成人注意缺陷/多动障碍评估中嵌入式症状效度指标的效用。

Examining the utility of the BAARS-IV scales as embedded symptom validity indicators for adult attention-deficit/hyperactivity disorder evaluations.

作者信息

Finley John-Christopher A, Robinson Anthony D, Cerny Brian M, Ovsiew Gabriel P, Pliskin Neil H, Calamia Matthew, Ulrich Devin M, Phillips Matthew S, Soble Jason R

机构信息

Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Department of Psychiatry, University of Illinois College of Medicine, Chicago, IL, USA.

出版信息

Clin Neuropsychol. 2025 Aug;39(6):1581-1597. doi: 10.1080/13854046.2024.2420376. Epub 2024 Oct 28.

DOI:10.1080/13854046.2024.2420376
PMID:39465583
Abstract

This study investigated whether extreme cut-scores on the Barkley Adult Attention-Deficit/Hyperactivity Disorder (ADHD) Rating Scale-Fourth Edition (BAARS-IV) self-report scales could serve as symptom overreporting indicators in adult ADHD evaluations. The sample consisted of 162 adults who underwent a neuropsychological evaluation for ADHD. Patients were classified into valid ( = 115) and invalid ( = 47) groups based on multiple criterion symptom validity tests. Overreporting cut-scores identified for each of the BAARS-IV scales demonstrated acceptable classification accuracy or better. The Current Total scale yielded the highest classification accuracy (area under the curve of .83). An optimal raw cut-score of ≥56 for this scale yielded 47% sensitivity when upholding ≥90% specificity. A cut-score of ≥31 for the Current Inattention scale (90% specificity; 47% sensitivity) and ≥29 for the Current Sluggish Cognitive Tempo scale (88% specificity; 46% sensitivity) were also relatively strong indicators of overreporting. The Current Total and Current Sluggish Cognitive Tempo scales captured nonredundant aspects of symptom validity, and using them together increased sensitivity to 57% while maintaining ≥90% specificity. Findings provide preliminary support for the criterion and construct validity of extreme cut-scores on the BAARS-IV Current Sluggish Cognitive Tempo, Current Inattention, and Current Total scales as indicators of ADHD symptom overreporting. However, employing the cut-scores from the Current Sluggish Cognitive Tempo (≥29) and Current Total (≥56) together may be the most promising way to detect overreporting. Scores above both of these cut-points should, at a minimum, prompt further investigation into the validity of a patient's reported symptoms.

摘要

本研究调查了《巴克利成人注意力缺陷/多动障碍评定量表(第四版)》(BAARS-IV)自陈量表上的极端划界分数是否可作为成人注意力缺陷多动障碍(ADHD)评估中症状过度报告的指标。样本包括162名接受ADHD神经心理学评估的成年人。根据多项标准症状效度测试,将患者分为有效组(n = 115)和无效组(n = 47)。为BAARS-IV各量表确定的过度报告划界分数显示出可接受的分类准确性或更高。当前总分量表的分类准确性最高(曲线下面积为0.83)。该量表的最佳原始划界分数≥56,在保持≥90%特异性时,敏感性为47%。当前注意力不集中量表划界分数≥31(特异性90%;敏感性47%)和当前认知迟缓量表划界分数≥29(特异性88%;敏感性46%)也是过度报告的相对有力指标。当前总分量表和当前认知迟缓量表捕捉了症状效度的非冗余方面,同时使用它们可将敏感性提高到57%,同时保持≥90%的特异性。研究结果为BAARS-IV当前认知迟缓量表、当前注意力不集中量表和当前总分量表上的极端划界分数作为ADHD症状过度报告指标的标准效度和结构效度提供了初步支持。然而,同时使用当前认知迟缓量表(≥29)和当前总分量表(≥56)的划界分数可能是检测过度报告最有前景的方法。至少,高于这两个切点的分数应促使进一步调查患者报告症状的效度。

相似文献

1
Examining the utility of the BAARS-IV scales as embedded symptom validity indicators for adult attention-deficit/hyperactivity disorder evaluations.考察巴尔斯成人注意缺陷多动障碍评定量表第四版(BAARS-IV)作为成人注意缺陷/多动障碍评估中嵌入式症状效度指标的效用。
Clin Neuropsychol. 2025 Aug;39(6):1581-1597. doi: 10.1080/13854046.2024.2420376. Epub 2024 Oct 28.
2
Using Depression and Anxiety Self-report Inventory Cutoffs to Screen for Invalid Psychiatric Symptom Overreporting During Diagnostic Evaluations for Attention-deficit/Hyperactivity Disorder.使用抑郁和焦虑自评量表临界值筛查注意缺陷/多动障碍诊断评估期间无效的精神症状过度报告情况。
J Psychiatr Pract. 2025 Jul 1;31(4):201-208. doi: 10.1097/PRA.0000000000000865.
3
The Internal, External, and Diagnostic Validity of Sluggish Cognitive Tempo: A Meta-Analysis and Critical Review.认知速度迟缓的内部、外部和诊断效度:一项元分析与批判性综述
J Am Acad Child Adolesc Psychiatry. 2016 Mar;55(3):163-78. doi: 10.1016/j.jaac.2015.12.006. Epub 2015 Dec 23.
4
Validation of the Arabic ADHD rating Scale-5 for adolescents in Saudi Arabia using structural equation modeling.使用结构方程模型对沙特阿拉伯青少年的阿拉伯语注意缺陷多动障碍评定量表-5进行验证。
Sci Rep. 2025 Jul 24;15(1):26866. doi: 10.1038/s41598-025-12976-7.
5
Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.针对5至18岁儿童注意力缺陷多动障碍(ADHD)的家长培训干预措施。
Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD003018. doi: 10.1002/14651858.CD003018.pub3.
6
Methylphenidate for children and adolescents with autism spectrum disorder.用于治疗自闭症谱系障碍儿童和青少年的哌醋甲酯
Cochrane Database Syst Rev. 2017 Nov 21;11(11):CD011144. doi: 10.1002/14651858.CD011144.pub2.
7
Clinical symptoms, signs and tests for identification of impending and current water-loss dehydration in older people.老年人即将发生和当前失水脱水的识别的临床症状、体征及检查
Cochrane Database Syst Rev. 2015 Apr 30;2015(4):CD009647. doi: 10.1002/14651858.CD009647.pub2.
8
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
9
Generalized Anxiety Disorder 7-item (GAD-7) and 2-item (GAD-2) scales for detecting anxiety disorders in adults.用于检测成人焦虑症的广泛性焦虑障碍7项(GAD - 7)和2项(GAD - 2)量表。
Cochrane Database Syst Rev. 2025 Mar 25;3(3):CD015455. doi: 10.1002/14651858.CD015455.
10
Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.安非他酮用于治疗成人注意力缺陷多动障碍(ADHD)。
Cochrane Database Syst Rev. 2017 Oct 2;10(10):CD009504. doi: 10.1002/14651858.CD009504.pub2.